|
National Stock Number(NSN): 6505-01-156-2144 (6505011562144, 011562144)
| NIIN: |
01-156-2144 |
Item Name: |
ALUMINUM HYDROXIDE GEL,DRIED,CAPSULES |
INC: |
42761
|
| FSC: |
6505
|
Assignment Date: |
Jun-20-1983 |
CRIT: |
N |
IIG: |
42761 |
| ISC: |
2 |
Date Standardized: |
Aug-07-1990 |
HMIC: |
P |
DODIC: |
|
| NSC: |
4 |
Cancellation Date: |
Apr-01-1998 |
PMIC: |
A |
FIIG: |
A510U0 |
| ESD: |
|
Schedule B: |
|
DEMIL: |
A |
DEMIL INT: |
|
| TIIC: |
1 |
Originator: |
KX |
ADPEC: |
|
RPDMRC: |
|
| Part Number |
CAGE |
Company |
Status |
RN CC |
RN VC |
DAC |
RN AAC |
RN FC |
RN SC |
RN JC |
SADC |
HCC |
MSDS |
|
90-0247 |
64616
|
DEFENSE MEDICAL STANDARDIZATION BOARD |
H |
5 |
1 |
4 |
KX |
|
|
|
|
|
|
|
DIALUME |
03884
|
ARMOUR PHARMACEUTICAL CO DIV OF RORER-POULEC RORER INC |
H |
5 |
1 |
|
|
|
|
|
|
|
|
|
DIALUME CAPSULES |
03884
|
ARMOUR PHARMACEUTICAL CO DIV OF RORER-POULEC RORER INC |
H |
5 |
1 |
|
|
|
|
|
|
|
|
|
NDC00053-3250-01 |
03884
|
ARMOUR PHARMACEUTICAL CO DIV OF RORER-POULEC RORER INC |
H |
3 |
2 |
|
|
|
|
|
|
|
|
|
NDC00075-3250-01 |
04518
|
AVENTIS PHARMACEUTICALS PRODUCTS INC. |
H |
3 |
2 |
4 |
ZZ |
|
|
|
|
|
|
| MOEC |
SOS |
A A C |
R C |
S L C |
CIIC |
U P Q |
U S C |
Unit Price |
UI |
UICF |
MCD |
Action Date |
C/H |
| DA |
S9M |
L |
Z |
M |
U |
1 |
A |
$11.26 |
BT |
|
C2201X- |
Feb-01-1993 |
H |
| DF |
JDC |
L |
|
M |
U |
1 |
F |
$15.22 |
BT |
|
------- |
Jun-01-1995 |
H |
| DN |
JDC |
L |
|
M |
U |
1 |
N |
$15.22 |
BT |
|
9L----- |
Nov-01-1994 |
H |
| DS |
JDC |
L |
|
M |
U |
1 |
D |
$15.22 |
BT |
|
------- |
Nov-01-1994 |
H |
| MOEC |
PC |
Phrase |
QPA |
UOM |
OOU |
JTC |
| DA |
K |
U/I CONTAINS 100EA |
000 |
|
|
|
| DF |
K |
U/I CONTAINS 100EA |
000 |
|
|
|
| DN |
K |
U/I CONTAINS 100EA |
000 |
|
|
|
| DS |
K |
U/I CONTAINS 100EA |
000 |
|
|
|
Technical Characteristics Information
| MRC |
Requirement Statement |
Reply Statement |
| AKJA |
ACTIVE MEDICAMENT MEDICINAL STRENGTH |
500.000 MILLIGRAMS ALUMINUM HYDROXIDE GEL, DRIED ACTIVE INGREDIENT |
| AKJC |
CAPSULE TYPE |
ANY ACCEPTABLE |
| CQCT |
PRIMARY CONTAINER TYPE |
BOTTLE |
| CQLS |
CAPSULE CONTENT FORM |
ANY ACCEPTABLE |
| CYLZ |
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY |
100.000 |
| SUPP |
SUPPLEMENTARY FEATURES |
MEDSEP ITEM FOR DOD,ARMOUR PHARM |
| MOE Rule |
Former MOER |
Effective |
AMC |
AMSC |
IMC |
IMCA |
Collaborators |
Receivers |
| A111 |
|
Jul-18-1997 |
3 |
H |
|
|
|
|
| FSKX |
|
Jul-18-1997 |
3 |
H |
|
|
|
|
| N9LM |
|
Jul-18-1997 |
3 |
H |
|
|
|
|
|